Lipoprotein-associated phospholipase A2 predicted cardiovascular disease in obstructive sleep apnea syndrome

Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for cardiovascular disease (CVD). As a new inflammatory biomarker of CVD, rare attention has been paid to the roles of lipoprotein-associated phospholipase (Lp-PLA2) in OSAS studies. In this study, we aimed to investigate the corr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Respiratory medicine 2020-03, Vol.163, p.105881-105881, Article 105881
Hauptverfasser:	Xu, Chenyu, Yu, Fenfang, Mao, Shan, Shi, Ying, Li, Qian, Fang, Surong, Tan, Yan, Gu, Wei, Ye, Liang
Format:	Artikel
Sprache:	eng
Schlagworte:	Apnea Arrhythmia Biomarker Biomarkers Blood diseases Cardiac arrhythmia Cardiovascular disease Cardiovascular disease (CVD) Cardiovascular diseases Cholesterol Congestive heart failure Coronary artery Coronary artery disease Coronary vessels Correlation analysis Enzymes Health risks Heart failure Hypertension Independent sample Inflammation Laboratories Lipoprotein-associated phospholipase (Lp-PLA2) Lipoproteins Metabolism Normal distribution Obstructive sleep apnea syndrome (OSAS) Oxygen saturation Phospholipase Phospholipase A2 Regression analysis Risk analysis Risk factors Sleep Sleep apnea Sleep disorders Software Standard deviation Subgroups Variance analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!